Z-LEHD-fmk Options
Name your selection: Name need to be fewer than one hundred figures Select a group: Struggling to load your collection resulting from an mistakeSifalimumab meets Most important endpoint of reduction in world-wide illness action rating (SRI-four), and displays clinically important advancement in pores and skin and joint indicators, patient reported